The yield of active 2-year treasury bonds dropped by 9BP to 1.16%, which was 9BP upside down from the current 1-year treasury bond yield. The yield of active 2-year treasury bonds dropped by 9BP to 1.16%, which was 9 BP upside down from the current 1-year treasury bond yield.The turnover of Shanghai, Shenzhen and Beijing exceeded 1 trillion yuan, 15.6 billion yuan more than the previous day. Up to now, the turnover of Shanghai, Shenzhen and Beijing exceeded 1 trillion yuan, 15.6 billion yuan more than the previous day. Among them, the turnover of Shanghai Stock Exchange was 378.3 billion yuan, that of Shenzhen Stock Exchange was 611.9 billion yuan, and that of Beizheng 50 was 10.5 billion yuan.Survey: More than 40% of analysts expect the Bank of Japan to raise interest rates this month, but most think that January next year is the best time. According to the latest survey, observers of the Bank of Japan predict that January is the most likely time to raise interest rates next time, but more than 40% of the respondents still expect to take action next week. According to the survey, about 52% of the 52 economists surveyed expect the Bank of Japan to raise the policy interest rate from 0.25% in January, compared with 32% in the last survey. About 44% of the respondents expect the central bank to take action at the end of the two-day meeting on December 19, down from 53% in the last survey. The survey results show that observers believe that the Bank of Japan's policy meeting this month is likely to move or not to move to a large extent. About 88% of the respondents said that the earliest possible time to raise interest rates in their risk scenarios is next week. Another equally high data shows that Japan's economic and price environment will justify raising interest rates this month.
Zhengzhou plans to identify three 4A-level scenic spots. On December 12th, it was reported that through the procedures of "voluntary declaration, step-by-step recommendation, landscape review, on-site inspection and party group research", Zhengzhou Municipal Bureau of Culture, Radio, Film and Tourism plans to identify three scenic spots, including Zhongmu Zhengzhou Haichang Ocean Park, Gongyi Qinglong Mountain Ecological Tourism Zone and Guancheng Zhengzhou Shangdu Ancient City Tourist Zone, as national 4A-level tourist attractions. The publicity period is 5 working days from December 9.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.Zhejiang has published a list of the top 500 enterprises. According to the news released by Zhejiang in WeChat official account, Zhejiang Institute of Science and Technology Information organized the evaluation of innovation ability of high-tech enterprises, and recently selected the top 500 high-tech enterprises in Zhejiang Province in 2024. Among them, Hangzhou Hikvision Digital Technology Co., Ltd., Ningbo Oaks Electric Co., Ltd. and Xinhua San Technology Co., Ltd. are in the top three.
Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.Binhua Co., Ltd. set up a new equipment technology company in Shandong. According to the enterprise search APP, Shandong Hualu Dingcheng Equipment Technology Co., Ltd. was established recently. The legal representative is Dong Hongbo, with a registered capital of 10 million yuan. Its business scope includes: cloud computing equipment technical services; Intelligent basic manufacturing equipment manufacturing; Intelligent basic manufacturing equipment sales. Enterprise equity penetration shows that the company is wholly owned by Binhua shares.The liquor sector moved up, Tianyoude Liquor rose daily, Gujing Distillery rose by more than 4%, and Huangtai Liquor, Shunxin Agriculture, Laobaigan Liquor and Yilite followed suit.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13